Bonn spin-out secures investment in its series A round.

Viamet Pharmaceuticals has raised $60m in a series D round featuring Novartis, Eli Lilly and Astellas, days after withdrawing its IPO plans.

Birmingham spin-out Serascience is acquired by Abingdon Health.

The Federal Ministry of Education and Research funds ImevaX with $7.5m.

China-based conglomerate Fosun has invested in cancer testing company Check-Capand courier service Beijing ZJS Express through two of its subsidiaries.

Medical device company Portal Instruments has received $11m in a series A round featuring investment vehicle Sunrise, to develop needle-free drug delivery systems.

The Amgen and Celgene-backed pharmaceutical company raised the cash after pulling in $72m in venture funding over two years.

Medical device company MID Labs has raised $51m in a round featuring Softbank's Chinese divsion, to develop eye surgery devices and expand across the US and China.

Phase 1 Ventures will be an accelerator programme.